PetMed Express Gestion
Gestion contrôle des critères 2/4
Le PDG PetMed Express est Leslie C. Campbell, nommé en Aug2025, a un mandat de moins d'un an. La rémunération annuelle totale est $ 830.22K, composée du salaire de 93.3% et des bonus 6.7%, y compris les actions et options de la société. détient directement 0.38% des actions de la société, d'une valeur de $ 140.80K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 2 ans et 2 ans.
Informations clés
Leslie C. Campbell
Directeur général
US$830.2k
Rémunération totale
| Pourcentage du salaire du PDG | 93.35% |
| Durée du mandat du directeur général | less than a year |
| Propriété du PDG | 0.4% |
| Durée moyenne d'occupation des postes de direction | 2yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 2yrs |
Mises à jour récentes de la gestion
Recent updates
PETS: Rural King Partnership And Board Review Will Support Future Upside
Analysts have adjusted their price target for PetMed Express to reflect updated views on revenue growth, profit margins, and a future P/E of 12.41. This has led to a revised valuation that aligns more closely with their current earnings expectations for the stock.PETS: Rural King White Label Pharmacy Will Support Future Margin Upside
Analysts have kept their price target on PetMed Express effectively unchanged at about $2.15, reflecting only very small tweaks to inputs such as discount rate, expected revenue trend, profit margin and future P/E assumptions. What's in the News PetMed Express announced a partnership with Rural King to launch a pet pharmacy service across Rural King retail stores and digital platforms, offering prescription medications, preventatives and other pet health products.PetMed Express: High-Risk Turnaround, Hidden Assets, Activism
Summary PetMed Express’ current valuation suggests investors are pricing in a significant deterioration in the franchise. Execution risk is substantial. The assets provide downside support - although continued operating losses will reduce that support. Ultimately, the investment case depends less on asset values and more on on whether management can stabilize revenue and translate operational improvements into earnings. PETS is more of an asset-backed special situation than an operational turnaround. Read the full article on Seeking AlphaPETS: Rural King Partnership Will Shape Future Margins And Earnings Outlook
Analysts have slightly reduced their price target on PetMed Express, attributing the change to a marginally lower discount rate and a modest increase in the assumed future P/E multiple as the main factors behind the revised outlook. What's in the News PetMed Express announced a partnership with Rural King to launch a new pet pharmacy offering across Rural King’s retail stores and digital platforms, focusing on prescription medications, preventatives and broader pet health products (Key Developments).PETS: Rural King Partnership Will Shape Future Margins And Earnings Multiple
Analysts have trimmed their price target on PetMed Express to reflect a fair value update from $3.00 to $2.15 as they incorporate more moderate expectations for revenue contraction, profit margins, and a higher future P/E multiple into their models. What's in the News PetMed Express announced a partnership with Rural King to launch a new pet pharmacy offering across Rural King retail stores and digital platforms, expanding access to prescription medications, preventatives and pet health products for Rural King customers (Key Developments).Getting In Cheap On PetMed Express, Inc. (NASDAQ:PETS) Is Unlikely
It's not a stretch to say that PetMed Express, Inc.'s ( NASDAQ:PETS ) price-to-sales (or "P/S") ratio of 0.3x right now...Some Confidence Is Lacking In PetMed Express, Inc. (NASDAQ:PETS) As Shares Slide 26%
To the annoyance of some shareholders, PetMed Express, Inc. ( NASDAQ:PETS ) shares are down a considerable 26% in the...
Cost Cuts And Digital Upgrades Will Strain Future Margins
Optimism regarding savings from PetCareRx integration could jeopardize future profitability if anticipated savings do not materialize.PetMed Express: Dip Or Rip, A Buy After Earnings
Summary PetMed Express stock could surge or sink after this week's quarterly earnings release, but don't read too much into this near-term event. A disappointing earnings release won't necessarily shatter the bull case, and could, in fact, push this stock back down to "back up the truck" price levels. Conversely, even if PETS rallies on strong results, this may not capture all of the potential long-term upside. Even if it takes time to take shape, improvements in PetMed's operating performance could ultimately send the stock back to prices north of $15 per share. Read the full article on Seeking AlphaWe Think PetMed Express (NASDAQ:PETS) Can Easily Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...Some PetMed Express, Inc. (NASDAQ:PETS) Shareholders Look For Exit As Shares Take 28% Pounding
PetMed Express, Inc. ( NASDAQ:PETS ) shares have retraced a considerable 28% in the last month, reversing a fair amount...PetMed Express: Why (And Why Not) The Rebound Could Continue
Summary PetMed Express (PETS) surged 35.8% on Nov. 7, following the online pet pharmacy's latest quarterly earnings release. Despite the massive post-earnings surge, further upside may lie ahead, if the turnaround continues. PetMed's management team is implementing a strategy change, not just cost-cutting measures, to continue improving the company's fiscal performance. Although many risks and uncertainties remain, given the outsized impact further improvements could have on the PETS stock price, at the very least add it to your watchlist. Read the full article on Seeking AlphaOptimistic Investors Push PetMed Express, Inc. (NASDAQ:PETS) Shares Up 28% But Growth Is Lacking
PetMed Express, Inc. ( NASDAQ:PETS ) shares have had a really impressive month, gaining 28% after a shaky period...PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
There's been a notable change in appetite for PetMed Express, Inc. ( NASDAQ:PETS ) shares in the week since its...PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates
PetMed Express, Inc. ( NASDAQ:PETS ) last week reported its latest annual results, which makes it a good time for...PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price
Key Insights Using the Dividend Discount Model, PetMed Express fair value estimate is US$7.95 Current share price of...A Look At The Fair Value Of PetMed Express, Inc. (NASDAQ:PETS)
Key Insights PetMed Express' estimated fair value is US$11.85 based on 2 Stage Free Cash Flow to Equity Current share...PetMed Express (NASDAQ:PETS) Is Paying Out A Dividend Of $0.30
The board of PetMed Express, Inc. ( NASDAQ:PETS ) has announced that it will pay a dividend of $0.30 per share on the...Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Mar 31 2026 | US$830k | US$775k | -US$57m |
| Dec 31 2025 | n/a | n/a | -US$65m |
| Sep 30 2025 | n/a | n/a | -US$55m |
| Jun 30 2025 | n/a | n/a | -US$44m |
| Mar 31 2025 | US$78k | n/a | -US$6m |
| Dec 31 2024 | n/a | n/a | US$357k |
| Sep 30 2024 | n/a | n/a | -US$963k |
| Jun 30 2024 | n/a | n/a | -US$3m |
| Mar 31 2024 | US$143k | n/a | -US$7m |
| Dec 31 2023 | n/a | n/a | -US$3m |
| Sep 30 2023 | n/a | n/a | -US$547k |
| Jun 30 2023 | n/a | n/a | US$1m |
| Mar 31 2023 | US$203k | n/a | US$5m |
| Dec 31 2022 | n/a | n/a | US$9m |
| Sep 30 2022 | n/a | n/a | US$13m |
| Jun 30 2022 | n/a | n/a | US$17m |
| Mar 31 2022 | US$338k | n/a | US$19m |
| Dec 31 2021 | n/a | n/a | US$22m |
| Sep 30 2021 | n/a | n/a | US$25m |
| Jun 30 2021 | n/a | n/a | US$27m |
| Mar 31 2021 | US$274k | n/a | US$24m |
| Dec 31 2020 | n/a | n/a | US$31m |
| Sep 30 2020 | n/a | n/a | US$30m |
| Jun 30 2020 | n/a | n/a | US$28m |
| Mar 31 2020 | US$160k | n/a | US$26m |
Rémunération vs marché: La rémunération totale de Leslie C. ($USD 830.22K ) est dans la moyenne des entreprises de taille similaire sur le marché US ($USD 641.77K ).
Rémunération et revenus: La rémunération de Leslie C. a augmenté alors que l'entreprise n'est pas rentable.
PDG
Leslie C. Campbell (68 yo)
Ms. Leslie C. G. Campbell is Executive Chair of the Board of PetMed Express, Inc. She was Independent Chairman of the Board of PetMed Express, Inc. from January 5, 2024 and serves as its Independent Direct...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman of the Board | less than a year | US$830.22k | 0.38% $ 140.8k | |
| Chief Accounting Officer | 1.8yrs | US$426.84k | 0.21% $ 76.3k | |
| Chief Operating Officer | 2yrs | pas de données | pas de données | |
| Corporate Secretary & General Counsel | no data | pas de données | pas de données | |
| Vice President of People | 4.4yrs | pas de données | 0.077% $ 28.3k | |
| Corporate Controller & Corporate Secretary | 5.3yrs | pas de données | pas de données |
Gestion expérimentée: L'équipe de direction de PETS est considérée comme expérimentée (ancienneté moyenne 2 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman of the Board | 7.9yrs | US$830.22k | 0.38% $ 140.8k | |
| Independent Director | 1.2yrs | US$146.11k | 0.16% $ 59.6k | |
| Independent Director | 2yrs | US$150.71k | 0.20% $ 74.4k | |
| Lead Independent Director | 2yrs | US$161.74k | 0.20% $ 75.2k | |
| Independent Director | less than a year | US$103.33k | 0.16% $ 59.6k |
Conseil d'administration expérimenté: Le conseil d'administration de la PETS n'est pas considéré comme expérimenté ( 2 années d'ancienneté moyenne), ce qui suggère un nouveau conseil d'administration.
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/06/29 19:45 |
| Cours de l'action en fin de journée | 2026/06/29 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2026/03/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d'analyse utilisé pour générer ce rapport sont disponibles sur notre page Github, nous proposons également des guides pour apprendre à utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
PetMed Express, Inc. est couverte par 15 analystes. 1 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Erin Wilson Wright | BofA Global Research |
| Kristine Koerber | Citizens JMP Securities, LLC |
| David Westenberg | CL King & Associates, Inc. |